<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Iranian Journal of Virology</title>
<title_fa>مجله ویروس شناسی ایران</title_fa>
<short_title>Iran J Virol</short_title>
<subject>Medical Sciences</subject>
<web_url>http://journal.isv.org.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>1735-5680</journal_id_issn>
<journal_id_issn_online>2588-5030</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.21859/isv</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1395</year>
	<month>6</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2016</year>
	<month>9</month>
	<day>1</day>
</pubdate>
<volume>10</volume>
<number>2</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Evaluation of anti-hepatitis E virus antibody among hemodialysis patients in Gorgan, north of Iran</title>
	<subject_fa>عمومى</subject_fa>
	<subject>General</subject>
	<content_type_fa>پژوهشي</content_type_fa>
	<content_type>Original article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;div&gt;&lt;strong&gt;Background and Aims:&lt;/strong&gt; Hepatitis E virus is a public health concern and about a third of people in the world live in endemic areas. Although HEV is believed to be transmitted by fecal-oral routes between humans in low sanitary conditions, but evidence of transmission have been reported in hemodialysis (HD) patients.&lt;br&gt;
&lt;strong&gt;Materials and Methods:&lt;/strong&gt; Aim of present study was to determine the prevalence of anti-HEV antibody among HD patients in Gorgan, north of Iran. In this cross-sectional study, totally 300 HD patients from May to December 2014 were tested for detection of anti-HEV IgG and IgM by commercial HEV enzyme-linked immunosorbent assay (ELISA) kit. Demographic variables were collected in pre-designed questionnaires.&lt;br&gt;
&lt;strong&gt;Results:&lt;/strong&gt; Out of 300 individuals, 148 (49.3%) were male and 152 (50.7%) were female. The overall anti-HEV IgG seroprevalence rate was 4%. Result showed significant association between anti-HEV IgG and duration of dialysis (p = 0.03), but there were no significant differences between the subjects grouped according to gender, Ethnicity, dialysis per week and age. No anti-HEV IgM were detected in patients.&lt;br&gt;
&lt;strong&gt;Conclusions: &lt;/strong&gt;Since our finding showed statically significant relationship between duration of hemodialysis and anti-HEV. Therefore, hemodialysis maybe be considered as a risk factor in HEV transmission. However further studies are needed to confirm our data.&lt;/div&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>HEV, Hemodialysis, Seroprevalence, Iran</keyword>
	<start_page>13</start_page>
	<end_page>18</end_page>
	<web_url>http://journal.isv.org.ir/browse.php?a_code=A-10-115-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Hamed</first_name>
	<middle_name></middle_name>
	<last_name>Naziri</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>Hamed.naziri65@gmail.com</email>
	<code>10031947532846002986</code>
	<orcid>10031947532846002986</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>1.	Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Alireza</first_name>
	<middle_name></middle_name>
	<last_name>Tahamtan</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>alireza.tmn@gmail.com</email>
	<code>10031947532846002987</code>
	<orcid>10031947532846002987</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>1.	Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Abdolvahab</first_name>
	<middle_name></middle_name>
	<last_name>Moradi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>abmoradi@yahoo.com</email>
	<code>10031947532846002988</code>
	<orcid>10031947532846002988</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>2.	Department of Microbiology, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Alijan</first_name>
	<middle_name></middle_name>
	<last_name>Tabarraei</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>alijant@yahoo.com</email>
	<code>10031947532846002989</code>
	<orcid>10031947532846002989</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>2.	Department of Microbiology, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
